key: cord-0816869-t1tubtbm
authors: Moug, Susan; Carter, Ben; Myint, Phyo Kyaw; Hewitt, Jonathan; McCarthy, Kathryn; Pearce, Lyndsay
title: Decision-Making in COVID-19 and Frailty
date: 2020-05-06
journal: Geriatrics (Basel)
DOI: 10.3390/geriatrics5020030
sha: e4a35fb2631c282557d90e3b47618e25fb5b73fb
doc_id: 816869
cord_uid: t1tubtbm

We write in response to the COVID-19 pandemic and the important recognition of co-existing frailty [COVID-19 rapid guideline: critical care in adults; NICE NG159] [...].

We write in response to the COVID-19 pandemic and the important recognition of co-existing frailty [COVID-19 rapid guideline: critical care in adults; NICE NG159] [1] . There is no doubt that difficult decisions have been made and are continuing to be made across the UK. These decisions will become increasingly difficult with the continued narrowing of the clinical criteria for the escalation of treatment, as has been seen in other countries globally. Frailty has been placed at the forefront, with professional associations responding to the NICE NG159 by proposing a frailty score as part of the clinical assessment [2] . There is no doubt that increasing frailty (irrespective of the scale or score applied) is associated with poorer outcomes in both medical and surgical patients, with increased ITU admissions, prolonged length of stay, increased care needs on discharge and mortality all reported [3, 4] . However, these studies were not performed during a viral pandemic and while we, like all clinicians, await published evidence on COVID-19, we would like to highlight some points to consider when making clinical decisions based on frailty [5] .

When using frailty scores, clinicians should be familiar with how to score patients accurately. The subtleties of difference between Clinical Frailty Scores may identify patients to be frail (Clinical Frailty Score 5) rather than vulnerable (CFS 4) and as such impact their treatment or therapy options. Clinicians should also be aware of the different scores and how to apply them [this includes the two different Clinical Frailty Scores (1-7 and 1-9) ]. Many societies provide training modules online [2] .

Frailty has been shown to be independent of age when predicting poorer outcomes [4] . As a result, clinicians should be aware that frailty is not a certainty in older adults and that younger adults (those under 65 years of age) can be frail too [6] . Assumptions should not be made solely on age.

This is where the grey area lies, and where shared decision-making with patients, relatives, carers, and other and/or experienced clinicians is vital. The additional challenges of limited 'face to face' discussions of this nature for COVID-19 patients and their next of kin cannot be underestimated.

Rapid Guideline: Critical Care in Adults

Supporting Implementation of NICE Critical Care Guidelines (NG159)

Frailty in an older inpatient population: Using the clinical frailty scale to predict patient outcomes

Frailty predicts mortality in all emergency surgical admissions regardless of age. An observational study

COPE Study: COVID-19 in Older People. Royal College of Surgeons Covid Research Group

Frailty Exists in Younger Adults Admitted as Surgical Emergency Leading to Adverse Outcomes